Abstract
Lipids in women change towards a more atherogenic profile, basically an increase in LDL, at menopause [9]. Estrogen therapy which is used to treat the symptoms of menopause, also leads to changes in the lipid profile, most often a decrease in LDL and an increase in HDL and triglycerides
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agnani G, Bard JM, Candelier L et al. (1991) Interaction of Lp B, Lp B:E, Lp B: C-III and Lp B:C-III: E lipoproteins with the LDL receptor on HeLa cells. Arteriosclerosis 11: 1021–1029.
Alaupovic P (1982) The role of apoliproteins in lipid transport processes. Ric Clin Lab 12: 3–21.
Barbaras R, Puchois P, Fruchart JC et al. (1987) Cholesterol efflux from cultured adipose cells is mediated by Lp AI particles but not by Lp AI:AII particles. Biochem Biophys Res Commun 142: 63–69.
Bard JM, Parra HJ, Douste-Blazy P, Fruchart JC (1990) Effect of pravastatin, an HMG CoA Reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition. Metabolism 39: 269–273.
Cambien F, Parra HJ, Arveiler D et al. (1990) Lipoprotein particles in patients with myocardial infarction and controls. Arteriosclerosis 82: 111–349 (abstr. 1380).
De Lignieres B, Basdevant A, Thomas G et al. (1985) Biological effects of estradiol 17 beta in postmenopausal women: oral versus percutaneous administration. J Clin End Metab 62: 536–541.
Frick MH, Ello O, Haapa K etal. (1987) Helsinki heart study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med 317: 1237–245.
Kandoussi A, Cachera C, Parsy D, Bard JM, Fruchart JC (1991) Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immunosorbent assay: apo B with apo C-III and apo B with apo E. J Immunoassay 12: 305–323.
Kannel NB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med 85: 447–452.
Lipid Research Clinics Program (1984) The lipid Research Clinics Coronary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251: 365–374.
Parra HJ, Mezdour H, Ghalim N, Bard JM, Fruchart JC (1990) Differential electroimmunoassay on ready to use plates for human Lp Al lipoprotein particles. Clin Chem 8: 1431–1435.
Puchois P, Kandoussi A, Fievet P et al. (1987) Apolipoprotein Al containing lipoproteins in coronaary artery disease. Atherosclerosis 68: 35–40.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Bard, J.M., Amouyel, P., Fruchart, J.C. (1993). Influence of Oral and Percutaneous Estrogen Therapy on the Lipoprotein Particle Profile of Postmenopausal Women. In: Steinmetz, A., Schneider, J., Kaffarnik, H. (eds) Hormones in Lipoprotein Metabolism. Recent Developments in Lipid and Lipoprotein Research. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84855-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-84855-1_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-55995-5
Online ISBN: 978-3-642-84855-1
eBook Packages: Springer Book Archive